Pharmafile Logo

Pepperl+Fuchs GB Limited

Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

77 Ripponden Road, Oldham, Lancashire, OL1 4EL, United Kingdom
+44 (0)161 6336431

 Latest Content from PMHub 

Rare Diseases – not as rare as you think

Julie Cox reflects on our passion working in the rare disease space - helping to bring vital education to healthcare professionals, to benefit patients

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Rare and Orphan Diseases

Why we need authentic and personalised communications in the evolving rare disease space. By Sarah Mikhailov, Managing Director, Brand at Havas Life Medicom

Origins’ Strategy Offering Explained

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

Applying Vibrotactile Stimulation to Improve Parkinson’s

Videos and Podcasts | February 16, 2023 | Impetus Digital

Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

Impetus Digital’s Virtual Learning Programs named PM360’s Most Innovative Services of 2022

Press Releases | February 16, 2023 | Impetus Digital

About the AwardToronto, ON, December 15, 2022 — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Impetus Digital’s Virtual...

End-to-end patient strategy: Making a treatment for patients, with patients

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Press Releases | February 13, 2023 | OPEN Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...